COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 3092: Articles 30911-30920  | Next

Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza
Abbott, T. R., Dhamdhere, G., Liu, Y., Lin, X., Goudy, L. E., Zeng, L., Chemparathy, A., Chmura, S., Heaton, N., Debs, R., Pande, T., Endy, D., La Russa, M., Lewis, D. B., Qi, L. S.
10.1101/2020.03.13.991307 — Posted: 2020-03-14
SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches
Lukassen, S., Chua, R. L., Trefzer, T., Kahn, N. C., Schneider, M. A., Muley, T., Winter, H., Meister, M., Veith, C., Boots, A. W., Hennig, B. P., Kreuter, M., Conrad, C., Eils, R.
10.1101/2020.03.13.991455 — Posted: 2020-03-14
Accurate Identification of SARS-CoV-2 from Viral Genome Sequences using Deep Learning
Lopez-Rincon, A., Tonda, A., Mendoza-Maldonado, L., Claassen, E., Garssen, J., Kraneveld, A. D.
10.1101/2020.03.13.990242 — Posted: 2020-03-14 Discussion: Onsite
A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV
Yuan, M., Wu, N. C., Zhu, X., Lee, C.-C. D., So, R. T. Y., Lv, H., Mok, C. K. P., Wilson, I. A.
10.1101/2020.03.13.991570 — Posted: 2020-03-14 Discussion: Onsite
The architecture of SARS-CoV-2 transcriptome
Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N., Chang, H.
10.1101/2020.03.12.988865 — Posted: 2020-03-14 Discussion: Onsite
Differential Antibody Recognition by Novel SARS-CoV-2 and SARS-CoV Spike Protein Receptor Binding Domains: Mechanistic Insights
D'Annessa, I., Marchetti, F., Colombo, G.
10.1101/2020.03.13.990267 — Posted: 2020-03-14
Reinfection could not occur in SARS-CoV-2 infected rhesus macaques
Bao, L., Deng, W., Gao, H., Xiao, C., Liu, J., Xue, J., Lv, Q., Liu, J., Yu, P., Xu, Y., Qi, F., Qu, Y., Li, F., Xiang, Z., Yu, H., Gong, S., Liu, M., Wang, G., Wang, S., Song, Z., Zhao, W., Han, Y., Zhao, L., Liu, X., Wei, Q., Qin, C.
10.1101/2020.03.13.990226 — Posted: 2020-03-14 Discussion: Onsite | Offsite
High sensitivity detection of SARS-CoV-2 using multiplex PCR and a multiplex-PCR-based metagenomic method
Li, C., Debruyne, D., Spencer, J., Kapoor, V., Liu, L. Y., Zhang, B., Lee, L., Feigelman, R., Burdon, G., Liu, J., Oliva, A., Borcherding, A., Xu, J., Urban, A. E., Liu, G., Liu, Z.
10.1101/2020.03.12.988246 — Posted: 2020-03-14 Discussion: Onsite
Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2).
Lei, C., Su, B., Dong, H., Bellavia, A., Di Fenza, R., Safaee Fakhr, B., Gianni, S., Grassi, L. G., Kacmarek, R., Araujo Morais, C. C., Pinciroli, R., Vassena, E., Berra, L.
10.1101/2020.03.09.20033530 — Posted: 2020-03-13
Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19
Berra, L., Lei, C., Su, B., Dong, H., Safaee Fakhr, B., Grassi, L. G., Di Fenza, R., Gianni, S., Pinciroli, R., Vassena, E., Araujo Morais, C. C., Bellavia, A., Spina, S., Kacmarek, R., Carroll, R.
10.1101/2020.03.10.20033522 — Posted: 2020-03-13 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).